
Nearly 10% of Precision Trials Are Rescue Studies. When a Phase 1 biomarker-driven trial stalled under its first CRO, Precision stepped in. Sites activated ahead of expectations. First patient dosed immediately after screening.
hubs.ly/Q04ht7RT0

English















